Skip to content

Comparison of the effect of matcha tea and chamomile tea consumption on the severity of early dysmenorrhea

Comparison of the effect of matcha tea and chamomile tea consumption on the severity of early dysmenorrhea

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240526061895N1
Enrollment
114
Registered
2024-06-05
Start date
2024-06-08
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severity of primary dysmenorrhoea.

Interventions

Intervention 1: Intervention group with matcha tea: In this study, the matcha tea product, which is in the form of a powder product, will be used. so that the samples of the intervention group with ma

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Being 18-40 years old Absence of pregnancy Having Iranian nationality having a regular menstrual cycle with a duration of 3-7 days and an interval of 21-35 days between periods Occurrence of first menstruation before the age of 18 having menstrual pain (menstrual pain 5 or more according to the visual pain scale, which indicates moderate and severe dysmenorrhea) Lack of known mental or physical illness according to the person's own statement Absence of gynecological disease (myoma, endometriosis, ovarian cyst and pelvic inflammatory disease) according to the person's own statement. Not allergic to food, especially green tea or chamomile Light and moderate bleeding during menstruation (absence of clot removal) Not using oral contraceptives, benzodiazepines, barbiturates, narcotics, some antidepressants such as fluoxetine, anticoagulants, and alcohol. Not experiencing major stressors such as separation of parents or death of first degree relatives in the last two months Not transferring to another university and graduating within the next five months

Exclusion criteria

Exclusion criteria: Unwillingness and consent to participate in the study Having known chronic mental and physical disorders

Design outcomes

Primary

MeasureTime frame
Quantitive pain intensity. Timepoint: The end of the first menstrual day of the cycle before the intervention and the first, second and third cycle after the intervention. Method of measurement: Visual pain scale.;Qualitative pain intensity. Timepoint: The end of the first menstrual day of the cycle before the intervention and the first, second and third cycle after the intervention. Method of measurement: McGill pain questionnaire.;Severity of symptoms associated with primary dysmenorrhea. Timepoint: The end of the first menstrual day of the cycle before the intervention and the first, second and third cycle after the intervention. Method of measurement: Andresh Milsom verbal scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Parisa Samadi

Tehran University of Medical Sciences

pmfsamadi@yahoo.com+98 21 6105 4216

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026